A recent article published in Journal of the International Society for Burn Injuries (“Burns”) highlights the benefits of Succor™ Combat Foam for Large Burn Wounds (CI-PRJ012) in a large-animal model. The study compared Succor™ for Burns to standard of care (silver sulfadiazine) and to untreated control in a swine thermal burn model to assess for wound healing properties both in the presence and absence of concomitant bacterial inoculation. Findings indicate that Succor™ decreases necrosis and bacterial colonization compared to no treatment, while appearing to perform comparably to the current standard of care. Study conclusions suggest that Succor™ is easily removed with the application of room-temperature water, may provide clinical advantages over silver sulfadiazine. See full article here.
Representative images of final wound evaluation at Day 7 post-injury: control, silver sulfadiazine, and Succor™ Combat Foam for Large Burn Wounds (CI-PRJ012).
Comments